Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Neuroscience

Procurement and Distribution of Study Medicines

Go back to Resources

Procurement and Distribution of Study Medicines

Authors:

Secondary:

Publisher:

Editor(s):

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials

Go back to Resources

Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Tailoring a comprehensive website to support a clinical research network

Go back to Resources

Tailoring a comprehensive website to support a clinical research network

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

The training documentation form-Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)

Go back to Resources

The training documentation form-Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Go back to Resources

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Authors:

Pagination:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial

Go back to Resources

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial

Go back to Resources

Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial

Authors:

Volume:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

Go back to Resources

Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal

Go back to Resources

Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care

Go back to Resources

Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care

Authors:

Volume:

Pagination:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››
Subscribe to Neuroscience
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification